Discover 281 paid clinical trials in West Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
West Virginia currently offers numerous opportunities for healthy volunteers and those with specific medical conditions to engage in paid research studies. Key locations such as Charleston, Huntington, and Morgantown are enrolling participants, granting access to emerging treatments and expert care.
Filter
1
Filter results
Results: 281
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: St. John's, Halifax, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: York Village ME, Boston MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase3, Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Portland ME, Scarborough ME, South Portland ME,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05624996
Phase3, Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Brewer ME, Westerly RI, Manchester NH, Worcester MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase2, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Augusta ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase2, Phase3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: Rockport ME, Belfast ME, Brunswick ME, Augusta ME,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase1, Phase2, Recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
for
Cigarette Smoking-Related Carcinoma
Location: Saint Johnsbury VT, Lebanon NH, Vineland NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05008848
Phase3, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Greenlawn NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Bar Harbor ME, Boston MA, Concord NH, New York NY,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Brewer ME, South Weymouth MA, Boston MA, Brighton MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase3, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for
Cervical Cancer
Location: Scarborough ME, Providence RI, Manchester CT,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT04831580
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer